In this study, PDHA1 and DLD expression levels were downregulated in patients with AD, and RT-qPCR results showed the same trend, which the abovementioned evidence suggests may provide new insights into the treatment of AD. This evidence concerns the gene PDHA1 and Alzheimer disease.